Navigation Links
Ventria Hires Director of Global Regulatory Affairs
Date:11/27/2007

JUNCTION CITY, Kan., Nov. 27 /PRNewswire/ -- Ventria Bioscience announced today that Quentin B. Kubicek, Ph.D. would be joining the company as Director, Global Regulatory Affairs.

Dr. Kubicek joins Ventria with more than 20 years experience in regulatory affairs and policy development related to plant biotechnology. Prior to joining Ventria, Quentin worked with InterAmerican Institute for Cooperation on Agriculture (IICA) where he developed regulatory policies on behalf of several Latin American and Caribbean governments for products derived from biotechnology. Quentin has also held regulatory positions with Dupont Nutrition and Health and the United States Department of Agriculture. He received his Ph.D. in Molecular Biology from Texas A&M University.

"Quentin's proven leadership, scientific credentials and his experience working in regulatory affairs and policy development will help accelerate Ventria's growth as we achieve our vision for affordable healthcare solutions," said Scott Deeter, President and CEO, Ventria Bioscience. "Quentin will lead Ventria's Global Regulatory Affairs Group," he said.

"I am excited to be joining the Ventria team at a time of rapid growth so that I can utilize my experience to help Ventria achieve its vision of delivering affordable health care products to the global community," said Kubicek.

A recent child health study showed that Ventria's Lactiva and Lysomin helped reduce the duration of diarrhea in children by 30 percent when added to rehydration solutions. Childhood diarrhea is the second leading killer of children, claiming 2 million lives annually according to the World Health Organization.

For more information, see our website at Ventria Bioscience http://www.ventria.com

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.


'/>"/>
SOURCE Ventria Bioscience
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ventrias Child Health Product Recognized for Its Promise
2. Pioneer Surgical Technology Hires Vice President of New Business Development
3. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
4. LehmanMillet Continues Expansion with Strategic Hires
5. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
6. Staffing Agency Hires Local Television News Team, Launches Broadband Network for Nurses
7. Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model
8. Flagship Global Health Hires Health Care Veteran Larsen to Head Marketing and Sales
9. Pioneer Surgical Technology Hires New Spinal Franchise Manager
10. ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support
11. FBR Capital Markets Hires Senior Healthcare Analyst
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... NJ (PRWEB) , ... August 16, 2017 , ... With low back pain afflicting 8 ... know what causes its kissing cousin – upper back pain. But this equally vexing condition ... treatment options, according to Kaixuan Liu, MD, PhD , founder and president of Atlantic ...
(Date:8/16/2017)... ... 2017 , ... “Mom, God's Got This: Jamie's Story” is the creation of published author, Karen ... has an insatiable appetite for God’s Word. , “I froze between the half walls, shelves ... packages of oatmeal. I have one to this day on proud display in my dining ...
(Date:8/15/2017)... Buffalo, NY (PRWEB) , ... August 15, 2017 , ... ... as maintenance treatment for multiple myeloma has been completed, with the team’s findings now ... Philip L. McCarthy, MD , Director of the Blood and Marrow Transplant Program at ...
(Date:8/15/2017)... MD (PRWEB) , ... August 15, 2017 , ... ... from BB&T. Horizon Goodwill CEO, John McCain said, “We are overwhelmed with gratitude ... and create opportunities for people who need assistance to both get a job ...
(Date:8/15/2017)... ... 15, 2017 , ... The V Foundation for Cancer Research, ... Foundation Wine Celebration raised nearly $9 million for cancer research during a full ... donations to support the study of BRCA mutation research in laboratories and clinics ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... Colo. , July 26, 2017 E.I. ... Guttridge and the Bimini SharkLab to custom design the worlds ... images of sharks in their native habitat. In preparation ... Discovery Channel,s Shark Week, Dr. Guttridge approached EIMI ... take pregnancy diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... 2017 The Galien Foundation announced today ... USA Award Nominees. Counted among the global health ... outstanding biomedical and technology product achievement that improves the human ... each candidate must be U.S. Food and Drug Administration (FDA) ... tremendous potential to impact human health. Sales data are not ...
(Date:7/24/2017)... -- IBM (NYSE: IBM ) has been recognized as ... (SSA) for the fourth year in a row. 1 ... in the Leaders quadrant have the highest scores for their ... the Leaders quadrant has the market share, credibility, and marketing ... technologies. These vendors demonstrate a clear understanding of market needs; ...
Breaking Medicine Technology: